Hyoscine 市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 4 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
预计 Hyoscine 市场在预测期内的复合年增长率为 4%，这归因于晕动病的有效药物，导致消费者对 Hyoscine 的认识提高。此外，旅行增加可能导致恶心、呕吐等晕动病，这进一步导致了东莨菪碱药物的采用。例如，根据 2018 年美国国家医学图书馆 (NIH) 的数据，晕动病是一种以旅行或运动为特征的常见疾病，并且频率是三分之一的人易患这种疾病，这导致对东莨菪碱的需求不断增加。此外，一些手术补充剂的增长也是推动东莨菪碱市场增长的因素之一，这些药物用于控制和减少唾液含量和胃酸、减缓肠道蠕动和防止呕吐的手术。此外，在手术和术后恢复中使用透皮莨菪碱贴剂的增加以及发展中国家对社区医疗保健的重视预计将为发展中国家提供有利可图的机会。然而，与东莨菪碱产品的制造和营销相关的严格监管可能会在一定程度上阻碍市场。
报告范围
莨菪碱是治疗晕动病的有效药物，用于治疗术后恶心、胃肠痉挛和呕吐。该药属于抗毒蕈碱家族，通过阻断神经系统内的一些乙酰胆碱作用起作用。
| By Type | |
| Hyoscine Butylbromide | |
| Hyoscine Hydrobromide |
| By Mode of Administration | |
| Oral | |
| Patches | |
| Injections |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
主要市场趋势
口服东莨菪碱有望在东莨菪碱市场占据主要市场份额
口服莨菪碱预计将贡献最大的部分，这归因于易于管理、易于获得以及在腹部肌肉痉挛和治疗晕动病方面的广泛偏好。与贴片和注射剂相比，口服片剂不需要处方，并且可以在药房轻松获得，从而降低医疗保健成本并进一步推动口服细分市场。此外，患者数量的增加和旅行人口的增加导致对东莨菪碱的高需求，推动口服东莨菪碱市场的增长。
To understand key trends, Download Sample Report
北美预计将在市场上占有重要份额，预计在预测期内也将如此
由于许多市场参与者从事药物制造、手术补充剂数量的增长、医疗保健问题的日益增长、医疗保健支出的增加以及完善的医疗保健基础设施的存在，预计北美将在全球 Hyoscine 市场占有重要的市场份额。
To understand geography trends, Download Sample Report
竞争格局
所研究的市场具有中等竞争力，并且有几家国际和本地公司在这个市场上运营。市场上的一些公司是 Caleb Pharmaceuticals, Inc, Baxter International, Alkaloids Corporation., Alchem International Pvt。有限公司、广州汉方制药、MYUNGMOON PHARM CO., LTD. 和 Perrigo。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rise in Consumer Awareness Towards Hyoscine
-
4.2.2 Increase in Travelling
-
-
4.3 Market Restraints
-
4.3.1 Regulatory Framework
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type
-
5.1.1 Hyoscine Butylbromide
-
5.1.2 Hyoscine Hydrobromide
-
-
5.2 By Mode of Administration
-
5.2.1 Oral
-
5.2.2 Patches
-
5.2.3 Injections
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Caleb Pharmaceuticals, Inc
-
6.1.2 Baxter International
-
6.1.3 Alkaloids Corporation.
-
6.1.4 Alchem International Pvt. Ltd
-
6.1.5 Guangzhou HanFang Pharmaceutical
-
6.1.6 MYUNGMOON PHARM CO.,LTD.
-
6.1.7 Perrigo
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Hyoscine Market market is studied from 2018 - 2026.
What is the growth rate of Hyoscine Market?
The Hyoscine Market is growing at a CAGR of 4% over the next 5 years.
Which region has highest growth rate in Hyoscine Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Hyoscine Market?
North America holds highest share in 2021.
Who are the key players in Hyoscine Market?
Caleb Pharmaceuticals, Inc, Baxter International, Alkaloids Corporation, Alchem International Pvt. Ltd, Guangzhou HanFang Pharmaceutical are the major companies operating in Hyoscine Market.
